Clinical Trials Directory

Trials / Completed

CompletedNCT04913116

Generic Testing of Antigen Tests for COVID-19 in Denmark

Agreement of Antigen Tests on Oral Pharyngeal Swabs or Less Invasive Testing With PCR, for Detecting SARS-CoV-2 in Adults: A Prospective Nationwide Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
4,000 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate the analytical and clinical sensitivity and specificity of antigen tests performed as oropharyngeal swabs, outer nasal swabs, saliva swabs or breath tests including self-tests for SARS-CoV-2 towards standard RT-PCR testing. For each test 200 SARS-CoV-2 positive and 200 SARS-CoV-2 negative individuals previously defined by RT-PCR are tested. When tested an additional RT-PCR test is performed to verify status. Analytical sensitivity and specificity is determined on 210 SARS-CoV-2 positive samples with known Cq and 100 SARS-CoV-2 negative samples. 30 companies with a total of 55 tests participate in this nationwide study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComparison of antigen tests with RT-PCR as reference methodAntigen tests are performed locally including sampling from multiple anatomical testing sites. A reference oropharyngeal swab is always send for RT-PCR for SARS-CoV-2 at DTU to verify the status of the patient. RT-PCR samples from other anatomical test locations may be included.

Timeline

Start date
2021-01-18
Primary completion
2021-09-09
Completion
2021-09-09
First posted
2021-06-04
Last updated
2022-01-26

Locations

3 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04913116. Inclusion in this directory is not an endorsement.